Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Antoine Lafuma, John F Salmon, Julien Robert & Gilles Berdeaux. (2011) Treatment persistence and cost-effectiveness of latanoprost/latanoprost–timolol, bimatoprost/bimatoprost–timolol, and travoprost/travoprost–timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database. Clinical Ophthalmology 5, pages 361-367.
Read now
Read now
Philippe Denis, Antoine Lafuma & Gilles Berdeaux. (2008) Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database. Clinical Ophthalmology 2:2, pages 321-329.
Read now
Read now
Daniela Koleva, Paola De Compadri, Gianni Virgili, Alessandro Nobili & Livio Garattini. (2008) A critical review of the full economic evaluations of pharmacological treatments for glaucoma. Journal of Medical Economics 11:4, pages 719-741.
Read now
Read now
Antoine Lafuma, Carolini Laurendeau & Gilles Berdeaux. (2008) Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care: an analysis conducted on the UK General Practitioner Research Database. Journal of Medical Economics 11:3, pages 485-497.
Read now
Read now
Claude Le Pen, Marie Ligier & Gilles Berdeaux. (2005) Cost-effectiveness and cost-utility analysis of travoprost versus latanoprost and timolol in the treatment of advanced glaucoma in five European countries: Austria, France, Germany, The Netherlands and the United Kingdom. Journal of Medical Economics 8:1-4, pages 67-84.
Read now
Read now
Articles from other publishers (5)
Caroline Canavan, Joe West & Timothy Card. (2015) Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment. PharmacoEconomics 34:2, pages 181-194.
Crossref
Crossref
Renato De Natale, Antoine Lafuma & Gilles Berdeaux. (2009) Cost Effectiveness of Travoprost versus a Fixed Combination of Latanoprost/Timolol in Patients with Ocular Hypertension or Glaucoma. Clinical Drug Investigation 29:2, pages 111-120.
Crossref
Crossref
Jan D. Hirsch, Candis Morello, Renu Singh & Shira L. Robbins. (2007) Pharmacoeconomics of New Medications for Common Chronic Ophthalmic Diseases. Survey of Ophthalmology 52:6, pages 618-633.
Crossref
Crossref
Philippe Denis, Robert Launois, Marion Devaux & Gilles Berdeaux. (2006) Comparison of Diurnal Intraocular Pressure Control by Latanoprost versus Travoprost. Clinical Drug Investigation 26:12, pages 703-714.
Crossref
Crossref
Jean-Fran??ois Rouland, Gilles Berdeaux & Antoine Lafuma. (2005) The Economic Burden of Glaucoma and Ocular Hypertension. Drugs & Aging 22:4, pages 315-321.
Crossref
Crossref